| Literature DB >> 27877587 |
Bishnu Prasad Bastakoti1, Shih-Hsiang Liao2, Masamichi Inoue3, Shin-Ichi Yusa3, Masataka Imura1, Kenichi Nakashima4, Kevin C-W Wu5, Yusuke Yamauchi6.
Abstract
Polymeric micelles with core-shell-corona nanoarchitecture were designed for intracellular therapeutic anti-cancer drug carriers. Poly(styrene-b-acrylic acid-b-ethylene glycol) (PS-b-PAA-b-PEG) asymmetric triblock copolymer underwent self-assembly in aqueous solution to form spherical micelles with hydrophobic PS core, anionic PAA shell and hydrophilic PEG corona. The anti-cancer drug (doxorubicin, DOX) was successfully incorporated into the polymeric micelles. The in vitro release experiment confirmed that the release of DOX from the micelles was inhibited at pH 7.4. In contrast, an accelerated release of DOX was observed at mildly acidic conditions such as pH 4.5. The excellent biocompatibility of our PS-b-PAA-b-PEG-based micelles made the synthesized nano-carrier best suited for the delivery of anti-cancer drugs.Entities:
Keywords: 10.01; 10.13; anti-cancer drug carrier; block copolymer; core–shell–corona micelle; doxorubicin; frozen micelle
Year: 2013 PMID: 27877587 PMCID: PMC5090313 DOI: 10.1088/1468-6996/14/4/044402
Source DB: PubMed Journal: Sci Technol Adv Mater ISSN: 1468-6996 Impact factor: 8.090
Figure 1.(a) TEM image of PS-b-PAA-b-PEG micelles and (b) AFM image of DOX/PS–PAA–PEG. The scale bar is 50 nm.
Figure 2.Hydrodynamic diameter of PS-b-PAA-b-PEG micelles at pH (a) 7.4 and (b) 4.5, respectively.
Figure 3.(a) Absorption and (b) fluorescence spectra of (1) DOX and (2) DOX/PS–PAA–PEG, respectively.
Figure 4.(a) Dh and (b) ζ of DOX/PS–PAA–PEG as a function of DOX molar ratio. The concentration of polymer is fixed at 0.2 g l−1.
Figure 5.Drug release profiles of DOX/PS–PAA–PEG at pH 4.5 and 7.4.
Figure 6.Relative viability of BT-20 cells evaluated by MTT assay with different dosages of DOX/PS–PAA–PEG (blue) and PS-b-PAA-b-PEG micelles (red).